Brady Todd C — SEC Form 4 filings
SEC reporting owner CIK 1579179. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-12 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 250,000 shares, $418,450 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 183,238 shares, $580,760 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: purchase of 250,000 shares @ $1.67 ($418,450) in Aldeyra Therapeutics, Inc., filed 2026-06-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aldeyra Therapeutics, Inc. (ALDX) | President and CEO, Director | 4 | 1 leg · 250,000 sh · $418,450 | 2 legs · 183,238 sh · $580,760 | 4 |
| Evoke Pharma Inc (EVOK) | Director | 4 | — | — | 7 |
Form 4 filings — Brady Todd C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Purchase (P): 250,000 @ $1.67 | EDGAR |
| 2026-03-31 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 1,880,510 (derivative) @ $0 · Grant/award (A): 632,318 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Evoke Pharma Inc (EVOK) | Code (U): 27 · Disposition to issuer (D): 1,218 (derivative) · Disposition to issuer (D): 5,833 (derivative) · Disposition to issuer (D): 1,187 (derivative) | EDGAR |
| 2025-05-22 | 4 | Evoke Pharma Inc (EVOK) | Grant/award (A): 1,187 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 809,710 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | Evoke Pharma Inc (EVOK) | Grant/award (A): 5,833 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Evoke Pharma Inc (EVOK) | Grant/award (A): 14,625 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Sale (S): 97,914 @ $3.27 · Sale (S): 85,324 @ $3.05 · Grant/award (A): 1,081,201 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1579179 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →